Medical Tidbits, Leading Medical News Today

Your place for beaking medical news and career advice from top medical recruiters

Medtronic Acquires Medina Medical

DUBLIN– August 31, 2015 — Medtronic plc (NYSE:MDT) today announced it has acquired Medina Medical, a Menlo Park, Calif.-based and privately-held medical device company focused on commercializing state-of-the-art treatments for vascular abnormalities of the brain including cerebral aneurysms.  This acquisition is another example of the company’s commitment to its key growth strategy of therapy innovation. read more

Valeant And AstraZeneca To Partner On Brodalumab

US and EU regulatory submission planned in moderate-to-severe psoriasis in Q4 2015

LAVAL, Quebec, Sept. 1, 2015 /PRNewswire/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that its affiliate has entered into a collaboration agreement with AstraZeneca under which Valeant was granted an exclusive license to develop and commercialize brodalumab. read more

H. Lundbeck A/S increases its share capital by 545,917 shares (0.2777 % of outstanding shares) as a result of employee warrant exercise

Valby, Denmark, 2015-09-01 11:44 CEST (GLOBE NEWSWIRE) — Valby, Denmark, 1 September 2015 – H. Lundbeck A/S (Lundbeck) today announced that it has decided to increase its share capital by DKK 2,729,585, as a consequence of the exercise of employee warrants. read more

Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study

LONDON, Sept. 1, 2015 /PRNewswire/ — Abbott (NYSE: ABT) announced today positive one-year clinical results from ABSORB Japan, a multi-center, randomized trial comparing the safety and effectiveness of Abbott’s fully dissolving Absorb™ heart stent to XIENCE ®, Abbott’s market-leading, permanent drug eluting stent. The trial was conducted in 38 sites in Japan and enrolled 400 people with coronary artery disease, the most common form of heart disease. The results will be featured at a late-breaking session today at ESC Congress 2015, an annual event of the European Society of Cardiology that brings together cardiologists from around the world, with the goal of reducing the burden of cardiovascular disease.  In addition, the data was published simultaneously in the European Heart Journal.  read more

Novartis receives EU approval for Tafinlar® and Mekinist®, first combination approved for patients with aggressive form of melanoma

Basel, September 1, 2015 Novartis today announced that the European Commission has approved the combination of Tafinlar® (dabrafenib) and Mekinist® (trametinib) for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation. This is the first targeted therapy combination approved in the EU to treat patients with the most aggressive form of skin cancer[1], demonstrating improved overall survival versus the current standard of care with BRAF inhibitor monotherapy in two Phase III studies[2,3]. read more

Positive Benefits of the Nanostim Leadless Pacemaker  

ST. PAUL, MINN. & LONDON, ENGLAND, 01 september 2015 /ANP Pers Support/ — LEADLESS II Trial Results Published in The New England Journal of Medicine Confirm the Positive Benefits of the Nanostim Leadless Pacemaker.

Data from the LEADLESS II study also highlighted the St. Jude Medical Nanostim leadless pacemaker’s retrievability, projected longevity and the promising future of leadless pacing.

EISAI INC. AND PURDUE PHARMA ENTER WORLDWIDE COLLABORATION TO DEVELOP AND COMMERCIALIZE LEMBOREXANT

Tokyo, Japan and Stamford, CT – August 31, 2015 – Eisai Co., Ltd. and Purdue Pharma L.P. announced today that Eisai Inc., the U.S. subsidiary of Eisai Co., Ltd., and Purdue Pharma have entered into a worldwide collaboration agreement for the development and commercialization of Eisai’s clinical candidate lemborexant (development code : E2006), a dual orexin receptor antagonist entering Phase III clinical development for the treatment of insomnia. read more

 

For leading medical news and career advice in the medical field subscribe to Med Career News

Get Med Career News in your Inbox!

If you want to keep up with the latest news and career tips in the Medical Field subscribe today!

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.